BioXcel Therapeutics, Inc. Common Stock, Value, Issued
BioXcel Therapeutics, Inc. (BTAI) had Common Stock, Value, Issued of $31.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-13
- 2026-06-30: Common Stock, Value, Issued $31.00K.
- 2026-03-31: Common Stock, Value, Issued $27.00K.
- 2025-12-31: Common Stock, Value, Issued $76.00K.
- 2025-09-30: Common Stock, Value, Issued $73.00K.
| Period end | Common Stock, Value, Issued |
|---|---|
| 2026-06-30 | $31.00K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $27.00K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $76.00K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $73.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $60.00K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $59.00K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $49.00K 10-K · filed 2026-03-27 |
| 2024-09-30 | $42.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $40.00K 10-Q · filed 2024-08-06 |
| 2024-03-31 | $34.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $30.00K 10-K · filed 2025-03-28 |
| 2023-09-30 | $29.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $29.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $29.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $28.00K 10-K · filed 2024-03-22 |
| 2022-09-30 | $28.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $28.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $28.00K 10-Q · filed 2022-05-09 |
| 2021-12-31 | $28.00K 10-K · filed 2023-03-16 |
| 2021-09-30 | $28.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $28.00K 10-Q · filed 2021-08-10 |
| 2021-03-31 | $25.00K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $24.00K 10-K · filed 2022-03-11 |
| 2020-09-30 | $24.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $20.00K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $20.00K 10-Q · filed 2020-05-12 |
| 2019-12-31 | $18.00K 10-K · filed 2021-03-12 |
| 2019-09-30 | $18.00K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $16.00K 10-Q · filed 2019-08-06 |
| 2019-03-31 | $16.00K 10-Q · filed 2019-05-07 |
| 2018-12-31 | $16.00K 10-K · filed 2020-03-09 |
| 2018-09-30 | $16.00K 10-Q · filed 2018-11-09 |
| 2018-06-30 | $16.00K 10-Q · filed 2018-08-08 |
| 2018-03-31 | $16.00K 10-Q · filed 2018-05-14 |
| 2017-12-31 | $10.00K 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |